The trajectory of Sildenafil presents a complex picture for investors. While the initial launch generated significant gains, the end of its patent opened the floodgates to off-brand alternatives, dramatically https://orangebookmarks.com/story21699460/the-copyright-and-the-pharmaceutical-industry-a-volatile-bet